Surgical resection remains the cornerstone of management for primary cardiac tumors, offering excellent outcomes for benign lesions like myxomas but primarily palliative benefits for malignant sarcomas.
Answers are grounded in this paper and cite their sources.
May guide histology-specific counseling on cardiac tumor outcomes; leaves open the need for prospective trials on multimodal therapies.
Summary Primary neoplasms of the heart are relatively rare. Their incidence varies between 0.001% to 0.3% of individuals in autopsy series. Even the most common primary tumour – cardiac myxoma – is estimated to occur in fewer than two or three people per 100 000 population. When primary cardiac tumours occur consequences may be considerable because of the crucial nature of the various structures involved. The complications attributed to such tumours depend on their location, size, mobility, friability, and the invasiveness of tumour growth. Primary tumours of the heart and pericardium are more important for their local effects than for their potential metastatic behaviour. They usually present as rhythm disturbances, contractility abnormality, obstruction, valvular regurgitation, embolic event, or pericardial effusion. In some instances, presentation may mimic myocardial ischaemia, valvular disease, cardiomyopathy, or local infectious disease. Numerous imaging modalities (transthoracic and transoesophageal echocardiography, computed tomography and magnetic resonance imaging) have improved the diagnosis and the planning for surgery when a heart tumour is suspected or discovered. Benign cardiac tumours represent up to 75% of the cases. Surgical resection allows specification of the type of tumour in the majority of the cases. No randomised clinical trials have been carried out to determine the optimal therapy for primary cardiac tumours. The prognosis for survival in patients with cardiac tumours varies from excellent after resection of myxoma to dismal when malignant neoplasms have been diagnosed. Surgery may be the treatment of choice for small malignant tumours localised to the heart. Partial resection of large neoplasms to relieve mechanical effects might be considered in exceptional cases, especially in children. Whilst total resection of cardiac sarcomas may occasionally appear feasible, most operations are palliative and performed to relieve cardiac compression or haemodynamic obstruction. This paper reviews the most common benign and malignant cardiac tumours, summarises some interesting cases treated at our institution and gives an brief overview o f our experience during the last 15 years.
No takes yet. Share an insight, caveat, or question.
Carrel et al. (2011) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: